Breaking News
July 20, 2018 - High-performance porous polymeric material for chromatography applications
July 20, 2018 - New molecule shows great promise for future treatment of many cancers
July 20, 2018 - Immune T cells are built to react as fast as possible, shows study
July 20, 2018 - ZHX2 protein could offer a new treatment strategy for kidney cancer
July 20, 2018 - Health burdens of very high risk drinking are potentially large, study reveals
July 20, 2018 - Using miniature drug-filled nanocarriers to target headaches and tumors
July 20, 2018 - Researchers uncover cause for progression of prostate cancer to incurable stage
July 20, 2018 - Studies highlight issues regarding black lung, opioid overdose, police violence and more
July 20, 2018 - AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia
July 20, 2018 - Researchers are one step closer to developing eye drops to treat age-related macular degeneration (AMD)
July 20, 2018 - Patients maintain muscle mass five years after surgically induced weight loss
July 20, 2018 - AMSBIO introduces new, powerful CRISPR/Cas9 gene editing kits
July 20, 2018 - PureTech Health collaborates with Roche to advance oral administration of antisense oligonucleotides
July 20, 2018 - Analysis reveals disparities in cancer death rates among minority groups
July 20, 2018 - Dr Maddy Parsons receives Royal Microscopical Society Life Science Medal
July 20, 2018 - Study finds link between DNA methylation and non-alcoholic fatty liver disease
July 20, 2018 - Military personnel with head trauma and football players with suspected CTE show similar brain changes
July 20, 2018 - Vidac Pharma Announces Initiation of Phase 2b Clinical Trial of VDA-1102 Ointment in Patients with Actinic Keratosis
July 20, 2018 - KKR is buying Envision Healthcare in a nearly $10B deal
July 20, 2018 - Older people with broken bones face higher risk of death for up to 10 years
July 20, 2018 - A simple pill for meth addicts on the cards
July 20, 2018 - UA researchers to repurpose ketamine to reduce side effects in Parkinson’s patients
July 20, 2018 - Child psychiatrist available on call to help assess separated immigrant children
July 20, 2018 - High bitter-taste sensitivity linked to increased risk of cancer
July 20, 2018 - Falling temperatures may lead to rise in numbers of deaths from stroke
July 20, 2018 - Supplemental oxygen prevents rise in morning blood pressure in OSA patients
July 20, 2018 - High fruit and vegetable intake linked to reduced risk of breast cancer
July 20, 2018 - Careful patient selection may help achieve good outcomes for vaginal mesh surgery
July 20, 2018 - Researchers raise viability of cloned mice using somatic cell nuclear transfer method
July 20, 2018 - 3HP for Latent TB Infection Treatment | 2018 | Newsroom | NCHHSTP
July 20, 2018 - An orange a day keeps macular degeneration away: 15-year study
July 20, 2018 - Researchers elucidate how the brain drives trial-by-trial adaptation to compensate for errors
July 20, 2018 - Understanding triple-negative breast cancer to develop better treatments
July 20, 2018 - Study compares outpatient antibiotic prescribing with traditional medical, retail clinic settings
July 20, 2018 - Immediate Monitoring With ECG Patch Ups A-Fib Diagnosis Rate
July 20, 2018 - KHN’s ‘What the Health?’ Drug prices and unicorns
July 20, 2018 - Scientists seek to better protect the eye from glaucoma
July 20, 2018 - Football training could improve bone mineral density in prostate cancer patients
July 20, 2018 - Single genetic change in gut bacteria can lead to obesity
July 20, 2018 - Research uncovers new target for therapeutic intervention in breast cancer
July 20, 2018 - WFN to highlight clean air for brain health on World Brain Day 2018
July 20, 2018 - Health Highlights: July 17, 2018
July 20, 2018 - Mom’s marijuana winds up in breast milk
July 20, 2018 - Black men could be healthier if seen by black physicians, new research suggests
July 20, 2018 - Alcoholics have persistent difficulties with emotional communication after long-term abstinence
July 19, 2018 - Researchers unravel how ALL invades the central nervous system
July 19, 2018 - Mother’s microbiome determines offspring’s risk of developing autism
July 19, 2018 - Refining standards of maternal-fetal care
July 19, 2018 - Stitching single cells together any which way you want to
July 19, 2018 - Study identifies RNA molecules that regulate male hormones in prostate cancer
July 19, 2018 - New machine-learning model shows promise in predicting undiagnosed dementia
July 19, 2018 - Sleep supports antioxidant processes, study suggests
July 19, 2018 - MiRagen Therapeutics Announces Initiation of Phase 2 Clinical Trial of MRG-201
July 19, 2018 - Unique brain ‘fingerprint’ can predict drug effectiveness
July 19, 2018 - Life on the border: Struggling to survive in Jordan
July 19, 2018 - CT scans may raise brain tumor risk
July 19, 2018 - Moderate alcohol intake linked with improved male fertility
July 19, 2018 - Alcohol-related cirrhosis mortality on the rise among young adults
July 19, 2018 - Study uncovers new protein complex that shields broken DNA ends
July 19, 2018 - Regular sunscreen use protects young people from melanoma
July 19, 2018 - Using non-invasive brain recordings to characterize activity in deep structures
July 19, 2018 - Mediterranean diet could influence academic performance through effects on sleep quality
July 19, 2018 - Woman’s pregnancy history may be linked to Alzheimer’s disease risk
July 19, 2018 - Study calls for new gold standard in research to treat non-alcoholic steatohepatitis
July 19, 2018 - Cancer patients receiving anti-PD-1 therapies may experience delayed skin reactions
July 19, 2018 - Scientists study adverse effects of carbon, silicon nanotubes and carbon nanofibers
July 19, 2018 - Keck Hospital of USC receives Magnet recognition for excellence in nursing
July 19, 2018 - Scientists identify hidden signals in RNAs that control protein synthesis
July 19, 2018 - Quadrivalent HPV Vaccine Not Tied to Spontaneous Abortion
July 19, 2018 - FDA OKs first drug made to reduce excessive sweating
July 19, 2018 - New Finnish study compares surgical treatment of shoulder impingement syndrome to placebo surgery
July 19, 2018 - New findings do no support caffeine as effective appetite suppressant or weight-loss aid
July 19, 2018 - Kite collaborates with Gadeta to develop novel gamma delta TCR therapies for various cancers
July 19, 2018 - Study evaluates Neoteryx’s VAMS technology for monitoring HbA1c levels of diabetic children
July 19, 2018 - New clinical trial examines use of adrenaline to treat cardiac arrests
July 19, 2018 - Early surgical intervention may improve outcomes for patients with mitral valve disease
July 19, 2018 - Prolonged preoperative opioid use linked to adverse outcomes after total knee and hip arthroplasty
July 19, 2018 - Biophysicists use infrared sensor as new method for drug discovery
July 19, 2018 - Rat study shows negative effects of perinatal exposure to phthalates
July 19, 2018 - Children with disabilities endure long waits for life-changing medical equipment
New oxytocin chemical sensor could be first step towards early diagnosis of autism

New oxytocin chemical sensor could be first step towards early diagnosis of autism

image_pdfDownload PDFimage_print

Is it going to be possible to detect features of autism at birth? At the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw a sensor has come into being that means this may become a reality. The main recognition component of the new device is a polymer layer with a carefully designed structure. It recognizes molecules of oxytocin, a compound considered to be one of the biomarkers of autism.

Molecules of many different chemical compounds circulate in human blood. One of them is oxytocin, a compound more commonly known as the ‘love hormone’. Distinct changes in its blood concentration suggest the patient may potentially be predisposed to autism. It will be possible to detect these changes using a new chemical sensor, designed and fabricated at the Institute of Physical Chemistry of the Polish Academy of Sciences (IPC PAS) in Warsaw, which selectively recognizes even small amounts of oxytocin. A description of work on the device, funded by the Iuventus Plus grant from the Ministry of Science and Higher Education of Poland, has just been published in Biosensors and Bioelectronics, a scientific journal of high reputation.

In medicine, there are occasional breakthroughs that result in a qualitative improvement in the health of entire populations. In the 20th century, such moments include the discovery of antibiotics or the spread of vaccination. Today, it seems that in the near future a revolution on a similar scale will come about thanks to new diagnostic devices that are sensitive, accurate, fast, and above all small and very cheap. Available at all times and to everybody – perhaps even wearable or incorporated in everyday items? – these instruments could detect diseases at very early stages of development, thereby contributing to a dramatic increase in treatment efficacy. The key element of this type of innovative diagnostic instrument must be reliable sensors capable of reacting to the presence of even a small number of molecules of highly discriminative with respect to selected chemical compounds.

“In the devices developed in our research team, the role of recognizing the sought after compounds is played by carefully fabricated and equally carefully produced polymer layers. The main idea here is simple, i.e., for each compound to be recognized we try to build a layer of a polymer with cavities – molecular voids – that are as best as possible suited to the shape as well as physical and chemical properties of the molecules of the chemical compound that we want to recognize in the sensor’s surroundings,” says Prof. Wlodzimierz Kutner (IPC PAS).

‘Stamping’ the shape and properties of molecules of the selected compound in the polymer matrix is a technique known as molecular imprinting. Functional monomers are introduced into a solution containing the molecules that are to be detected. They attach to characteristic binding sites on the molecules to be imprinted. A cross-linking monomer is then introduced which rapidly binds to the functional monomers. The target recognition layer is formed after polymerization of the cross-linking monomer, and then rinsing out from the structure thus formed the molecules of the compound selected for detection.

Prof. Kutner’s team has already developed many polymer layers that selectively react to even low concentrations of important chemicals, including melamine, nicotine, albumin and neopterin (one of the biomarkers of cancer). Oxytocin has just joined this group.

“It’s one thing to capture oxytocin molecules in a polymer layer, but quite another to read the information that the molecular cavities have been filled,” notes Dr. Zofia Iskierko from Prof. Kutner’s team and explains: “For us, the signal of the presence of oxytocin in the recognition layer is a change in electrical capacitance. That is why we produce these layers on small gold electrodes. We insert the electrodes into a tube through which a solution of blood (in our tests artificial blood) flows. The oxytocin molecules sink into the cavities of the polymer layer, thus changing the electrical capacitance of the measuring system.”

In experimental tests, it turned out that the new sensor detects micromolar concentrations of oxytocin and reacts to its presence even when it is surrounded by molecules of a very similar structure. Professor Kutner’s team is working on increasing the sensitivity of the sensor to a level that allows detection of nanomolar concentrations. The aim here is to achieve a sensitivity that allows a single, small drop of blood to be used to carry out a variety of diagnostic tests. The experiments performed at the IPC PAS labs also showed that the polymer recognition layer is relatively durable and allows multiple measurement repetitions without detriment to their sensitivity and selectivity.

Changes in blood oxytocin concentration alone do not make it clear whether a person is predisposed to autism. Before the diagnosis is made, the concentration of at least a few other substances (biomarkers) characteristically associated with this disease should be checked.

“Our oxytocin chemical sensor is really only a first step towards building a more advanced medical device that diagnoses a predisposition to autism. For some time, we have been working on polymer layers that respond to the presence of two other compounds associated with autism, namely, melatonin (which should not be confused with melamine) and gamma-aminobutyric acid,” stresses the leader of the research project Dr. Piyush S. Sharma (IPC PAS).

Tagged with:

About author

Related Articles